AwardTape / Contracts / HT9425-25-F-E074
HT9425-25-F-E074: $1.2M Defense Health Agency Award to Laulima Government Solutions, LLC
Combined long term efferocytosis and enhanced antibody-dependent cell-mediated cytotoxicity response hiv vaccine clinical trial to investigate safety and immunogenicity of new vaccine candidates in support of the war fighter.. Contracting activity: ARMY MED RES ACQ ACTIVITY. Estimated completion: 2027-09-29.
$1.2M contract action / $1.2M cumulative ceiling / COMPETITION NOT STATED / 2027-09-29 completion / HT9425 ARMY MED RES ACQ ACTIVITY
1. Contract Summary & Primary Sources
| Contract Number (PIID) | HT9425-25-F-E074 (unhyphenated: HT942525FE074) · Parent Vehicle: W81XWH-19-D-0011 |
|---|---|
| Prime Contractor (Awardee) |
Laulima Government Solutions, LLC
(Maryland)
FY2024-FY2026 Federal Defense Portfolio: $19.0M obligated across 26 contracts
|
| Obligated Amount | $1,169,926 ($1.2M) |
| Cumulative Face Value / Ceiling | USAspending Base IDV Ceiling: $1,169,926 |
| USAspending / FPDS Obligation History | Base Record Obligated: $1,169,926 (signed 2025-09-25, latest FPDS action 2025-09-25) · 2 Issued Delivery/Task Order(s) totaling $2,771,433 |
| Awarding Branch / Agency | Defense Health Agency |
| Contracting Command & DoDAAC | HT9425: ARMY MED RES ACQ ACTIVITY |
| Competition & Contract Structure | COMPETITION NOT STATED · Delivery Order / Cost-Plus-Fixed-Fee (CPFF) |
| Product / Service & Industry Codes | PSC R405 (Support- Professional: Operations Research/Quantitative Analysis) · NAICS 541715 (Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)) |
| Work Locations & Funding | Primary Place of Performance: Maryland |
| Estimated Completion Date | 2027-09-29 |
| Verified Primary Sources |
2. Verbatim Announcement & Scope Breakdown
USAspending / FPDS Transaction Description (Contract HT942525FE074)
Combined long term efferocytosis and enhanced antibody-dependent cell-mediated cytotoxicity response hiv vaccine clinical trial to investigate safety and immunogenicity of new vaccine candidates in support of the war fighter.
3. Subcontractor, Supply Chain & Capture Intelligence
For Tier-2 / Tier-3 Subcontractors & Suppliers
Subcontracting & Material Supply Window
- Prime Awardee: Laulima Government Solutions, LLC
- Delivery Runway: Active through 2027-09-29
- Requirement Scope: Combined long term efferocytosis and enhanced antibody-dependent cell-mediated cytotoxicity response hiv vaccine clinical trial to investigate safety and immunogenicity of new vaccine candidates in support of the war fighter.
- Federal Supply Class: PSC R405 (Support- Professional: Operations Research/Quantitative Analysis)
- BD Action: Reference Prime Contract HT9425-25-F-E074 when contacting Laulima Government Solutions, LLC Supply Chain / Small Business Liaison Officer.
For Competing Primes & Capture Managers
Buying Command & Recompete Posture
- Buying Command: HT9425 (ARMY MED RES ACQ ACTIVITY)
- Acquisition Method: COMPETITION NOT STATED
- FOIA Jurisdiction: OSD/Joint Staff FOIA Requester Service Center (WHS ESD) (fallback; use FOIA.gov to route) (whs.mc-alex.esd.mbx.osd-js-foia-requester-service-center@mail.mil)
- Capture Action: Request Section B CLIN ceiling structure and Section C Statement of Work below to benchmark deliverable requirements.
Issued Task & Delivery Orders under HT9425-25-F-E074 (2 shown, $2.8M obligated)
| Order PIID | Obligated | Awardee | Start / Latest Action | End Date | Order Scope |
|---|---|---|---|---|---|
| W81XWH21F0124 | $2.8M | Laulima Government Solutions, LLC | 2021-03-22 / 2026-03-20 | 2026-09-30 | Wrair clinical trial support services |
| W81XWH21F0236 | -$37K | Laulima Government Solutions, LLC | 2021-06-14 / 2025-03-18 | 2022-06-13 | Wrair clinical trial support services |
Tier-2 Subcontract Reporting Status (FAR 52.204-10): Prime contractors report first-tier subcontracts of $30,000 or more to the Federal Subaward Reporting System (FSRS) by the end of the month following subcontract award. Under DFARS 252.219-7003, prime awards exceeding $750,000 ($1.5M for construction) carry mandatory small-business subcontracting plans. Component and subsystem suppliers should contact Laulima Government Solutions, LLC Supply Chain / Small Business Liaison referencing contract HT9425-25-F-E074.
Recent Contract Actions from Buying Office HT9425 (ARMY MED RES ACQ ACTIVITY)
| Date | Contract (PIID) | Prime Contractor | Amount | Completion | Scope Summary |
|---|---|---|---|---|---|
| 2025-11-28 | HT9425-25-F-E073 | TrillaMed | $14.9M | Sep 21, 2028 | TrillaMed gets $14.9M modification for Infectious Diseases, Fort Detrick, Maryland. Defense Health Agency $12.0M obligated now signed Sep 29... |
| 2025-09-16 | HT9425-25-D-E004 | Octapharma USA | $14.9M | - | Octapharma USA wins $14.9M contract for OctaplasLG Kits. Defense Health Agency. |
4. Underlying Contract Files (Section B Pricing & Section C Statement of Work)
Document Status: Not yet on file. The government publishes the award notice and obligation record above, but does not post the underlying Section C Statement of Work (SOW), Section B line-item pricing schedule (CLINs), or Sole-Source Justification & Approval (J&A) online.
Free DIY 5 U.S.C. 552 Generator ($0 Cost)
Pre-Filled FOIA Request Letter for HT9425-25-F-E074
Routed to OSD/Joint Staff FOIA Requester Service Center (WHS ESD) (fallback; use FOIA.gov to route) (whs.mc-alex.esd.mbx.osd-js-foia-requester-service-center@mail.mil) · Official Agency FOIA Portal ↗
Optional Anonymous Filing via AwardTape Research: Prefer to keep your company name off the agency's public FOIA log? Enter your work email and AwardTape will track or file this request under AwardTape Research and email you when the agency responds.